We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Takes Steps to Revolutionize Phase I Clinical Trials
FDA Takes Steps to Revolutionize Phase I Clinical Trials
January 20, 2006
Clinical investigators can begin to test microdoses of new investigational drugs in smaller numbers of people before beginning conventional Phase I clinical trials, according to new FDA guidances that could change the face of clinical trials.